• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

Percentage of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month

Dictionary: Timely review of regulatory cases that come from the field is important as it allows FDA to take appropriate regulatory action such as issuance of a warning letter to the regulated industry. This can lead to a timely correction of problems in the industry resulting in a safer food supply.

Information is current as of June 30, 2020.

Fiscal Year - 2020

Skip graphic and jump to text data

TimeTargetPercentage
Oct 2019N/A78
Nov 2019N/A62
Dec 2019N/A80
Jan 2020N/A91
Feb 2020N/A85
Mar 2020N/A83
Apr 2020N/A95
May 2020N/A86
Jun 2020N/A88
Jul 2020N/ATBD
Aug 2020N/ATBD
Sep 2020N/ATBD

FY 2020 YTD: 84%

Total number of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month

Fiscal Year - 2020
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2019N/A7
Nov 2019N/A8
Dec 2019N/A12
Jan 2020N/A10
Feb 2020N/A11
Mar 2020N/A5
Apr 2020N/A20
May 2020N/A12
Jun 2020N/A7
Jul 2020N/ATBD
Aug 2020N/ATBD
Sep 2020N/ATBD

FY 2020 YTD: 92

Total number of regulatory cases referred to OFS in the month that are due within the month

Fiscal Year - 2020
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2019N/A9
Nov 2019N/A13
Dec 2019N/A15
Jan 2020N/A11
Feb 2020N/A13
Mar 2020N/A6
Apr 2020N/A21
May 2020N/A14
Jun 2020N/A8
Jul 2020N/ATBD
Aug 2020N/ATBD
Sep 2020N/ATBD

FY 2020 YTD: 110

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.

-
-